FDA Inspection
Viatris Pharmaceuticals LLCViatris Pharmaceuticals LLC – FDA Inspection, Jan 26, 2018
Record Details
This FDA Inspection record concerns Viatris Pharmaceuticals LLC, with an inspection on January 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 08afda11-f4f3-4cc8-84bf-b96e255953ae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1038692
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Viatris Pharmaceuticals LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 18, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| February 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Viatris Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.